Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Kohji KUROYANAGI"'
Autor:
Shuichi KAI, Hisashi KOHMURA, Eiko HIRAIWA, Shigeru KOIZUMI, Katsumi ISHIKAWA, Shigeo KAWANO, Kohji KUROYANAGI, Norimichi HATTORI, Hirotaka CHIKAZAWA, Hiroshi KONDOH, Kayo SAKAKURA, Toshihito KADOTA, Norimitsu TAKAHASHI
Publikováno v:
The Journal of Toxicological Sciences. 19:57-67
Paclitaxel, an antineoplastic agent, was administered intravenously to Crj: CD (SD) rats daily at dose levels of 0 (saline and vehicle), 0.1, 0.3 and 1.0 mg/kg for 63 days prior to mating and during the mating period in males, and for 14 days prior t
Autor:
Shuichi Kai, Eiko Hiraiwa, Kayo Sakakura, Kohji Kuroyanagi, Hiroshi Kondoh, Hirotaka Chikazawa, Norimichi Hattori, Katsumi Ishikawa, Shigeo Kawano, Toshihito Kadota, Hisashi Kohmura, Norimitsu Takahashi, Shigeru Koizumi
Publikováno v:
The Journal of Toxicological Sciences. 19:69-91
Paclitaxel, an antineoplastic agent, was administered intravenously to pregnant Crj: CD (SD) rats daily at dose levels of 0 (saline and vehicle), 0.15, 0.3 and 0.6 mg/kg from day 7 to day 17 of gestation. Results were as follows: 1. The ossification
Autor:
Eiko Hiraiwa, Shigeo Kawano, Kohji Kuroyanagi, Kayo Sakakura, Norimichi Hattori, Norimitsu Takahashi, Katsumi Ishikawa, Shigeru Koizumi, Toshihito Kadota, Hirotaka Chikazawa, Hiroshi Kondoh, Hisashi Kohmura
Publikováno v:
The Journal of Toxicological Sciences. 19:1-9
Paclitaxel, an antineoplastic agent, was given to Crj: CD (SD) rats of both sexes at 38, 50, 65 and 85 mg/kg by single intravenous administration to investigate its acute toxicity. The results obtained are summarized as follows: 1. Tachypnea and decr
Autor:
Toshihito KADOTA, Hirotaka CHIKAZAWA, Hiroshi KONDOH, Katsumi ISHIKAWA, Shigeo KAWANO, Kohji KUROYANAGI, Norimichi HATTORI, Kayo SAKAKURA, Shigeru KOIZUMI, Eiko HIRAIWA, Hisashi KOHMURA, Shuichi KAI, Norimitsu TAKAHASHI
Publikováno v:
The Journal of Toxicological Sciences. 19:11-34
Paclitaxel, an antineoplastic agent, was intravenously given to Crj:CD (SD) rats of both sexes at 0 (saline), 0 (vehicle), 1.0 (low dose), 3.3 (intermediate dose) and 10.0 (high dose) mg/kg at five-day interval over one-month period (6 times in total
Autor:
Toshihito KADOTA, Hiroshi KONDOH, Hirotaka CHIKAZAWA, Kohji KUROYANAGI, Norimiti HATTORI, Katsumi ISHIKAWA, Shigeo KAWANO, Kayo SAKAKURA, Shigeru KOIZUMI, Eiko HIRAIWA, Shinji HISADA, Shuichi KAI, Hisashi KOHMURA, Norimitsu TAKAHASHI
Publikováno v:
The Journal of Toxicological Sciences. 19:35-55
Paclitaxel, an antineoplastic agent, was intravenously given to Crj:CD (SD) rats of both sexes at 0 (saline), 0 (vehicle), 1.0 (low dose), 3.3 (intermediate dose) and 10.0 (high dose) mg/kg at five-day interval over one-month period (6 times in total
Autor:
Katsumi Ishikawa, Satoshi Ohta, Shigeo Kawano, Hirotaka Chikazawa, Kohji Kuroyanagi, Hiroshi Kondo, Norimitsu Takahashi, Hisashi Kohmura, Shuichi Kai, Toshihito Kadota
Publikováno v:
The Journal of toxicological sciences. 15
Buspirone hydrochloride (buspirone), an anxiolytic drug, was administered orally to pregnant Crj: CD (Sprague-Dawley) rats from day 17 of gestation through day 20 of postpartum at dose levels of 2, 12 and 75 mg/kg/day. The summarized results obtained
Autor:
Shuichi Kai, Katsumi Ishikawa, Norimitsu Takahashi, Hirotaka Chikazawa, Shigeo Kawano, Satoshi Ohta, Hisashi Kohmura, Hiroshi Kondo, Kohji Kuroyanagi, Toshihito Kadota
Publikováno v:
The Journal of toxicological sciences. 15
Buspirone hydrochloride (buspirone), an anxiolytic drug, was administered orally to pregnant Crj : CD (Sprague-Dawley) rats from day 7 through 17 of gestation at dose levels of 2, 12 and 75 mg/kg/day. The summarized results obtained are as follows :
Autor:
Norimitsu TAKAHASHI, Shuichi KAI, Hisashi KOHMURA, Katsumi ISHIKAWA, Takashi TANAKA, Kohji KUROYANAGI, Yoshinori HAMAJIMA, Satoshi OHTA, Toshihito KADOTA, Shigeo KAWANO, Keiko OHTA, Yukako TAKEUCHI
Publikováno v:
The Journal of Toxicological Sciences. 11:263-279
VP 16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered intravenously to male Crj : CD (Sprague-Dawley) rats for 61 days and to female rats of the same strain for 14 days prior to mating at dose levels of 0.05, 0.2 and 0.8 mg/kg/day.
Autor:
Katsumi Ishikawa, Kohji Kuroyanagi, Satoshi Ohta, Hirotaka Chikazawa, Yukako Takeuchi, Hisashi Kohmura, Norimitsu Takahashi, Toshihito Kadota, Shigeo Kawano, Keiko Ohta, Shuichi Kai, Yoshinori Hamajima
Publikováno v:
The Journal of Toxicological Sciences. 11:123-161
VP 16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered intravenously to Crj : CD (Sprague-Dawley) rats of both sexes at dose levels of 0.05, 0.15, 0.5 and 1.5 mg/kg/day for three months with the object of examining its toxicity and
Autor:
Katsumi Ishikawa, Hisashi Kohmura, Satoshi Ohta, Yoshinori Hamajima, Keiko Ohta, Norimitsu Takahashi, Kohji Kuroyanagi, Shigeo Kawano, Shuichi Kai, Toshihito Kadota
Publikováno v:
The Journal of Toxicological Sciences. 11:17-49
VP 16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered orally to Crj : CD (Sprague-Dawley) rats of both sexes at dose levels of 3, 10, 30 and 100 mg/kg/day for one month with the object of examining its subacute toxicity and the rev